Clinical trial

CGM Utilization With IV Insulin EndoTool and Subcutaneous Insulin in the Neuro ICU

NCT05857007

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-07-19

PhaseN/A

Study timeline

Study start (actual)2023-07-19Date precision: day

Registry last updated2024-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusunresolved

Type 2 Diabetes Mellitusunresolved

Hyperglycemiaunresolved

Interventions

Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoidsDEVICE

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05857007 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.